Showing results (361-370 of 463) with videos related to
Sort By:
Pageof 47
Advances in Radiation Oncology|December 8, 2022
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation TherapyHusain Yar Khan, Mandana Kamgar, Amro Aboukameel, et al.Cancer|February 11, 2025
Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505Sameer H Patel, Sarah Colby, Davendra Sohal, et al.Journal of Ovarian Research|November 15, 2024
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumorsMary P Udumula, Faraz Rashid, Harshit Singh, et al.Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.American Journal of Clinical Oncology|September 1, 2007
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancerSameer P Desai, Basil F El-Rayes, Edgar Ben-Josef, et al.Journal of Pancreatic Cancer|September 28, 2019
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic CancerVaibhav Sahai, M Wasif Saif, Aparna Kalyan, et al.American Journal of Clinical Oncology|December 10, 2003
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II studySana Al-Sukhun, Mark M Zalupski, Edgar Ben-Josef, et al.Annals of Surgical Oncology|January 9, 2023
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)Sepideh Gholami, Sarah Colby, David P Horowitz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.Pageof 47